FDA's RSABE on NTIDs in R [RSABE / ABEL]

posted by CECIF – Colombia, 2018-03-01 22:08 (2033 d 02:37 ago) – Posting: # 18491
Views: 12,991

Dear Detlew

❝ I will try my best :cool:.


Felt like life-saving answer for me.

So I used your R code from the thread you sent me (Marvelous coding btw), on Helmut's datafile http://bebac.at/downloads/NTID.xls

And these are my results:

> FDA_Narrow_CECIF(filename)
        SwR ABE.Lower ABE.upper ratioDS_IC.lower ratioDS_IC.upper     uppRSABE
1 0.1243928 0.9429483  1.029172        0.2932383        0.6842668 -0.009828289


Now, If I understand correctly this is bioequivalent because:

1. 95% CI of RSABE criterion= -0.009828289 <0
2. Conventional ABE test: 0.9 < 0.9429483, 1.11>1.029172 (or is it also with conventional limits 0.8 and 1.25?).
3. Upper 90% CI of the ratio swT/swR: 0.6842668<=2.5

In addition to this, do I still have to demonstrate conventional bioequivalence for:

❝ 1. Period 1 vs period 2 (regular bioequivalence study)

❝ 2. Period 3 vs period 4 (replicated study)

❝ 3. Pooled analysis (Average periods 1 and 3 vs average period 2 and 4)

?
as they do here? https://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40301_Warfarin%20Sodium_Approv.pdf

In any case, many thanks.

Complete thread:

UA Flag
Activity
 Admin contact
22,759 posts in 4,775 threads, 1,627 registered users;
18 visitors (0 registered, 18 guests [including 6 identified bots]).
Forum time: 01:46 CEST (Europe/Vienna)

The only people who see the whole picture are the ones
who step out of the frame.    Salman Rushdie

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5